These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 15851257)

  • 1. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias.
    Schreieck J; Zrenner B; Deisenhofer I; Schmitt C
    Heart Rhythm; 2005 Jan; 2(1):10-4. PubMed ID: 15851257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.
    Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A
    J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias--feasibility and clinical outcome.
    Tilz RR; Makimoto H; Lin T; Rillig A; Deiss S; Wissner E; Mathew S; Metzner A; Rausch P; Kuck KH; Ouyang F
    Europace; 2014 Jul; 16(7):1040-52. PubMed ID: 24574495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions.
    Fiek M; Remp T; Fleckenstein M; Pohl T; Deiss M; Reithmann C
    J Interv Card Electrophysiol; 2015 Mar; 42(2):151-60. PubMed ID: 25620151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.
    Stevenson WG; Wilber DJ; Natale A; Jackman WM; Marchlinski FE; Talbert T; Gonzalez MD; Worley SJ; Daoud EG; Hwang C; Schuger C; Bump TE; Jazayeri M; Tomassoni GF; Kopelman HA; Soejima K; Nakagawa H;
    Circulation; 2008 Dec; 118(25):2773-82. PubMed ID: 19064682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.
    Oliveira M; Cunha P; Valente B; Portugal G; Lousinha A; Pereira M; Braz M; Delgado A; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):865-873. PubMed ID: 34857160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroanatomically guided catheter ablation of ventricular tachycardias causing multiple defibrillator shocks.
    Sra J; Bhatia A; Dhala A; Blanck Z; Deshpande S; Cooley R; Akhtar M
    Pacing Clin Electrophysiol; 2001 Nov; 24(11):1645-52. PubMed ID: 11816634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for catheter ablation of ventricular tachycardia].
    Deneke T; Israel CW; Krug J; Nentwich K; Müller P; Mügge A; Schade A
    Dtsch Med Wochenschr; 2013 Sep; 138(39):1952-6. PubMed ID: 24046136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of storms of ventricular tachycardia by epicardial ablation of isolated delayed potential in noncompaction cardiomyopathy.
    Chinushi M; Iijima K; Furushima H; Izumi D; Sato A; Yagihara N; Hasegawa K; Watanabe H; Soejima K; Aizawa Y
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):e115-9. PubMed ID: 21208238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Anter E; Hutchinson MD; Deo R; Haqqani HM; Callans DJ; Gerstenfeld EP; Garcia FC; Bala R; Lin D; Riley MP; Litt HI; Woo JY; Acker MA; Szeto WY; Zado ES; Marchlinski FE; Dixit S
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):494-500. PubMed ID: 21673018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for recurrent ventricular tachycardia after catheter ablation of post-infarction ventricular tachycardia.
    Yokokawa M; Desjardins B; Crawford T; Good E; Morady F; Bogun F
    J Am Coll Cardiol; 2013 Jan; 61(1):66-73. PubMed ID: 23122796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
    Marrouche NF; Verma A; Wazni O; Schweikert R; Martin DO; Saliba W; Kilicaslan F; Cummings J; Burkhardt JD; Bhargava M; Bash D; Brachmann J; Guenther J; Hao S; Beheiry S; Rossillo A; Raviele A; Themistoclakis S; Natale A
    J Am Coll Cardiol; 2004 May; 43(9):1715-20. PubMed ID: 15120835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.